Categories

IVD

We are an EN ISO 13485 certified EU-located company developing and producing CE IVD real-time PCR kits.

Our in vitro diagnostics fall into five categories: clinical genetics, hematology, pharmacogenetics, oncology and microbiology.

Our typical partners are end-users of the RT-PCR kits (mostly in CZ and SK), business partners and distributors. We are looking for business partners and/or distributors worldwide who can fit the portfolio of our products, either the whole or a part of it, to their sales strategy (see here).

gb GENETIC LACTO gb GENETIC LACTO

gb GENETIC LACTO gb GENETIC LACTO

The CE IVD real-time PCR kit is intended for detection of mutations LCT (C13910T) and LCT (G22018A) in the lactase gene in human genomic DNA. Detection is based on real-time polymerase chain reaction (qPCR) using fluorescently labelled probes (allelic discrimination).

More
gb HEMO GPIIIa (L33P) gb HEMO GPIIIa (L33P)

gb HEMO GPIIIa (L33P) gb HEMO GPIIIa (L33P)

The CE IVD real-time PCR kit is intended for detection of L33P mutation in GPIIIa (ITGB3) gene in human genomic DNA. Detection is based on real-time polymerase chain reaction (qPCR) using fluorescently labelled probes (allelic discrimination).

More
gb HEMO GPIa (C807T) gb HEMO GPIa (C807T)

gb HEMO GPIa (C807T) gb HEMO GPIa (C807T)

The CE IVD real-time PCR kit is intended for detection of C807T mutation in GPIa gene in human genomic DNA. Detection is based on realtime polymerase chain reaction (qPCR) using fluorescently labelled probes (allelic discrimination).

More
gb ONCO CLL gb ONCO CLL

gb ONCO CLL gb ONCO CLL

The CE IVD real-time PCR kit is intended for prognosis assessment in CLL patients by analysis of cDNA (reverse transcribed RNA) samples of human B lymphocytes obtained from peripheral blood. The kit is based on reverse transcription together with quantitative real-time polymerase chain reaction (qRT-PCR) using fluorescently labelled probes.

More